This J.P. Morgan healthcare conference is one of the largest and most informative healthcare investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.

On Monday, January 12, 2026, at 3:00 pm PT CEO and Co-founder Dominik Schumacher will present a company overview and update. The presentation will take place in the Mission Bay Room (32nd Floor) at The Westin St. Francis.

Read more about this event on the conference website.

We’re excited to be part of Pacifichem 2025 in Honolulu. Join us to explore how our innovative antibody conjugation technologies are forging new paths in chemistry to address global challenges.

From November 3–6, our team will join the global #ADC community at the 16^th World ADC San Diego 2025 to exchange ideas, spark innovation, and shape the future of antibody-drug conjugates together with leading scientists, innovators, and industry experts.

Our Vice President, Chemistry and Early Discovery, @Marc-André Kasper, will share how we are leveraging our differentiated linker-payload chemistry to unlock novel payload classes and expand the therapeutic potential of ADCs, bringing these innovations closer to the clinic.

See the graphic below for details on Marc’s presentation.

Hope to see you in San Diego!